Clostridiodes | List of Frontiers open access articles

Mini Review

Published on 16 May 2024

Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection

in Host and Microbe Associations

Kanika Sehgal
Paul Feuerstadt

Frontiers in Microbiomes

doi 10.3389/frmbi.2024.1399440

2,709 views
4 citations

Review

Published on 11 Sep 2020

Bacteriocins From LAB and Other Alternative Approaches for the Control of Clostridium and Clostridiodes Related Gastrointestinal Colitis

in Synthetic Biology

Svetoslav D. Todorov
Hye-Ji Kang
Iskra V. Ivanova
Wilhelm H. Holzapfel

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2020.581778

9,575 views
34 citations

Review

Published on 28 Jun 2022

Next-Generation Probiotic Therapy to Protect the Intestines From Injury

in Biofilms

Mecklin V. Ragan
Samantha J. Wala
Steven D. Goodman
Michael T. Bailey
Gail E. Besner

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.863949

11,314 views
32 citations

Review

Published on 24 May 2023

The human gut virome: composition, colonization, interactions, and impacts on human health

in Virology

Evan Pargin
Michael J. Roach
Amber Skye
Bhavya Papudeshi
Laura K. Inglis
Vijini Mallawaarachchi
Susanna R. Grigson
Clarice Harker
Robert A. Edwards
Sarah K. Giles

Frontiers in Microbiology

doi 10.3389/fmicb.2023.963173

17,730 views
62 citations

Mini Review

Published on 28 Jul 2022

The Potential of Honey as a Prebiotic Food to Re-engineer the Gut Microbiome Toward a Healthy State

in Nutrition and Sustainable Diets

Kathleen R. Schell
Kenya E. Fernandes
Erin Shanahan
Isabella Wilson
Shona E. Blair
Dee A. Carter
Nural N. Cokcetin

Frontiers in Nutrition

doi 10.3389/fnut.2022.957932

110,674 views
68 citations

Original Research

Published on 11 Jul 2022

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment

in Neuropharmacology

Yanfang Zheng
Xian Zhou
Chenxiang Wang
Jialin Zhang
Dennis Chang
Wenjing Liu
MingXing Zhu
Shuting Zhuang
Hong Shi
Xiaoning Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.890444

6,881 views
18 citations

Original Research

Published on 26 Jan 2023

Structure-guided design of a potent Clostridioides difficile toxin A inhibitor

in Antimicrobials, Resistance and Chemotherapy

Greg Hussack
Martin A. Rossotti
Henk van Faassen
Tomohiko Murase
Luiz Eugenio
Joseph D. Schrag
Kenneth K.-S. Ng
Jamshid Tanha

Frontiers in Microbiology

doi 10.3389/fmicb.2023.1110541

3,060 views
2 citations

Articles

Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection

Bacteriocins From LAB and Other Alternative Approaches for the Control of Clostridium and Clostridiodes Related Gastrointestinal Colitis

Next-Generation Probiotic Therapy to Protect the Intestines From Injury

The human gut virome: composition, colonization, interactions, and impacts on human health

The Potential of Honey as a Prebiotic Food to Re-engineer the Gut Microbiome Toward a Healthy State

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment

Structure-guided design of a potent Clostridioides difficile toxin A inhibitor